{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:06:34Z","timestamp":1780308394140,"version":"3.54.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijgc.2026.104683","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:44:13Z","timestamp":1775231053000},"page":"104683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Contemporary issues in the multi-disciplinary management of early-stage uterine sarcoma"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1962-7893","authenticated-orcid":false,"given":"Geoffrey Alan","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7617-916X","authenticated-orcid":false,"given":"Fabio","family":"Murtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1928-7454","authenticated-orcid":false,"given":"Marjan","family":"Rouzbahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Pulenzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harleen","family":"Toor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8439-3929","authenticated-orcid":false,"given":"Kathy","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Croke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoun Rachel","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/j.ijgc.2026.104683_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijgo.12613","article-title":"Uterine sarcomas","volume":"143","author":"Mbatani","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104683_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.101992","article-title":"Uterine leiomyosarcoma","volume":"35","author":"Bogani","year":"2025","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104683_bib3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ygyno.2018.09.010","article-title":"Uterine leiomyosarcoma: a review of the literature and update on management options","volume":"151","author":"Roberts","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2026.104683_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/IJWH.S117754","article-title":"Uterine sarcoma - current perspectives","volume":"9","author":"Benson","year":"2017","journal-title":"Int J Womens Health"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2559.2005.02284.x","article-title":"The evolving classification of soft tissue tumours: an update based on the new WHO classification","volume":"48","author":"Fletcher","year":"2006","journal-title":"Histopathology."},{"issue":"2","key":"10.1016\/j.ijgc.2026.104683_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2017.05.036","article-title":"Low-grade and high-grade endometrial stromal sarcoma: a National Cancer Database study","volume":"146","author":"Seagle","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104683_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/ijgc-2023-004582","article-title":"Gynecological sarcomas, surgical management: primary, metastatic, and recurrent disease","volume":"34","author":"Ferron","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104683_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ygyno.2022.07.031","article-title":"Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group","volume":"167","author":"Croce","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"14","key":"10.1016\/j.ijgc.2026.104683_bib10","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.12998\/wjcc.v7.i14.1753","article-title":"Current status of the adjuvant therapy in uterine sarcoma: a literature review","volume":"7","author":"Rizzo","year":"2019","journal-title":"World J Clin Cases"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/gyno.1996.0185","article-title":"Uterine leiomyosarcoma: analysis of treatment failures and survival","volume":"62","author":"Gadducci","year":"1996","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104683_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ygyno.2016.07.110","article-title":"Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: a systematic review and meta-analysis","volume":"143","author":"Bogani","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib13","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104683_bib14","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/a-1545-4279","article-title":"2020 WHO classification of female genital tumors","volume":"81","author":"H\u00f6hn","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41467-017-02602-0","article-title":"Integrative genomic and transcriptomic analysis of leiomyosarcoma","volume":"9","author":"Chudasama","year":"2018","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104683_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/modpathol.2017.42","article-title":"BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology","volume":"30","author":"Chiang","year":"2017","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104683_bib17","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/s41379-020-0535-y","article-title":"High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities","volume":"33","author":"Zou","year":"2020","journal-title":"Mod Pathol."},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41379-021-00922-7","article-title":"TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition","volume":"35","author":"Chiang","year":"2022","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41379-021-00855-1","article-title":"Uterine PEComas: correlation between melanocytic marker expression and TSC alterations\/TFE3 fusions","volume":"35","author":"Bennett","year":"2022","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.ijgc.2026.104683_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100611","article-title":"Unraveling the molecular landscape of uterine tumor resembling ovarian sex cord tumor: insights from a clinicopathological, morphologic, immunohistochemical, and molecular analysis of 35 cases","volume":"37","author":"Fl\u00eddrov\u00e1","year":"2024","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib21","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a001115","article-title":"ALK: a tyrosine kinase target for cancer therapy","volume":"3","author":"Holla","year":"2017","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1016\/j.ijgc.2026.104683_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231157645","article-title":"Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)","volume":"15","author":"P\u00e9rez-Fidalgo","year":"2023","journal-title":"Ther Adv Med Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104683_bib23","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/0284186X.2012.689111","article-title":"Diagnosis and treatment of sarcoma of the uterus. A review","volume":"51","author":"Trop\u00e9","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijgc.2026.104683_bib24","first-page":"1","article-title":"Uterine sarcomas: how to navigate an ever-growing list of subtypes","volume":"42","author":"Roy","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/RUQ.0000000000000454","article-title":"Ultrasound features of uterine sarcomas","volume":"35","author":"Oh","year":"2019","journal-title":"Ultrasound Q"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104683_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jcu.20386","article-title":"Can gray-scale and color Doppler sonography differentiate between uterine leiomyosarcoma and leiomyoma?","volume":"35","author":"Exacoustos","year":"2007","journal-title":"J Clin Ultrasound"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104683_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4274\/jtgga.galenos.2022.2021.9-17","article-title":"Effect of tumor morcellation in patients with early uterine sarcoma: a multicenter study in Germany","volume":"23","author":"Gitas","year":"2022","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"12","key":"10.1016\/j.ijgc.2026.104683_bib28","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1007\/s11547-024-01903-x","article-title":"Preoperative identification from occult leiomyosarcomas in laparoscopic hysterectomy and laparoscopic myomectomy: accuracy of the ultrasound scoring system (PRESS-US)","volume":"129","author":"Jiang","year":"2024","journal-title":"Radiol Med"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5152\/dir.2014.14053","article-title":"Uterine sarcomas: clinical presentation and MRI features","volume":"21","author":"Santos","year":"2015","journal-title":"Diagn Interv Radiol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00330-007-0787-7","article-title":"The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas","volume":"18","author":"Tamai","year":"2008","journal-title":"Eur Radiol"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104683_bib31","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1007\/s00330-016-4623-9","article-title":"Differentiation of uterine leiomyosarcoma from atypical leiomyoma: diagnostic accuracy of qualitative MR imaging features and feasibility of texture analysis","volume":"27","author":"Lakhman","year":"2017","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5334\/jbsr.2275","article-title":"Diagnostic performance of MRI to differentiate uterine leiomyosarcoma from benign leiomyoma: a meta-analysis","volume":"104","author":"Virarkar","year":"2020","journal-title":"J Belg Soc Radiol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104683_bib33","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.211658","article-title":"MRI evaluation of uterine masses for risk of leiomyosarcoma: a consensus statement","volume":"306","author":"Hindman","year":"2023","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/RCT.0000000000001656","article-title":"Uterine sarcoma or degenerating fibroid? Validating the new consensus magnetic resonance imaging algorithm for evaluating atypical uterine masses","volume":"49","author":"Horowitz","year":"2025","journal-title":"J Comput Assist Tomogr"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104683_bib35","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1007\/s00259-022-05700-4","article-title":"Head-to-head evaluation of [18F]FDG and [68 Ga]Ga-DOTA-FAPI-04 PET\/CT in recurrent soft tissue sarcoma","volume":"49","author":"Gu","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2017.02.019","article-title":"Uterine leiomyosarcoma: epidemiology, contemporary treatment strategies and the impact of uterine morcellation","volume":"145","author":"Ricci","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jmig.2016.01.022","article-title":"The role of endometrial biopsy in the preoperative detection of uterine leiomyosarcoma","volume":"23","author":"Hinchcliff","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib38","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0002-9378(90)91298-Q","article-title":"Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas","volume":"162","author":"Leibsohn","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104683_bib39","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/cncr.10382","article-title":"Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma","volume":"94","author":"Kawamura","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104683_bib40","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1245\/s10434-022-12697-5","article-title":"Percutaneous uterine needle biopsy with microscopic and array-CGH analyses for preoperative sarcoma diagnosis in patients with suspicious myometrial tumors on MRI: a prospective pilot study (SARCGYN)","volume":"30","author":"Smadja","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104683_bib41","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/PAS.0000000000001746","article-title":"Intraoperative frozen section biopsy of uterine smooth muscle tumors: a clinicopathologic analysis of 112 cases with emphasis on potential diagnostic pitfalls","volume":"45","author":"Lok","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ijgc.2026.104683_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejogrb.2019.03.017","article-title":"A more accurate method to interpret lactate dehydrogenase (LDH) isoenzymes\u2019 results in patients with uterine masses","volume":"236","author":"Di Cello","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ijgc.2026.104683_bib43","article-title":"Detection of circulating tumor DNA in patients with uterine leiomyomas","volume":"3","author":"Przybyl","year":"2019","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104683_bib44","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/annonc\/mdz124","article-title":"Surgery in reference centers improves survival of sarcoma patients: a nationwide study","volume":"30","author":"Blay","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijgc.2026.104683_bib45","first-page":"207","article-title":"McCarus minimally invasive hysterectomy: 20 years\u2019 experience-lessons learned","volume":"33","author":"McCarus","year":"2018","journal-title":"Surg Technol Int"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib46","doi-asserted-by":"crossref","first-page":"425.e1","DOI":"10.1016\/j.ajog.2017.12.218","article-title":"Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women","volume":"218","author":"Morgan","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"20","key":"10.1016\/j.ijgc.2026.104683_bib47","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1002\/cncr.28844","article-title":"Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma","volume":"120","author":"George","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ijgc.2026.104683_bib48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2018.06.007","article-title":"Uterine morcellation and survival in uterine sarcomas","volume":"101","author":"Bretthauer","year":"2018","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104683_bib49","doi-asserted-by":"crossref","first-page":"257.e1","DOI":"10.1016\/j.ajog.2015.08.076","article-title":"Contained tissue extraction using power morcellation: prospective evaluation of leakage parameters","volume":"214","author":"Cohen","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib50","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/AOG.0000000000001039","article-title":"Uncontained compared with contained power morcellation in total laparoscopic hysterectomy","volume":"126","author":"Winner","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104683_bib51","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ajog.2015.01.012","article-title":"A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature","volume":"212","author":"Liu","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: a National Cancer Database study","volume":"145","author":"Seagle","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104683_bib53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bpobgyn.2011.05.009","article-title":"Surgical treatment of uterine sarcoma","volume":"25","author":"Nam","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104683_bib54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Koh","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib55","first-page":"5818","article-title":"Fertility-sparing treatment of low-grade endometrial stromal sarcoma","volume":"8","author":"Jin","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib56","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e46","article-title":"Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma","volume":"28","author":"Nasioudis","year":"2017","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib57","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/ijgc-2018-000063","article-title":"Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis","volume":"29","author":"Nasioudis","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104683_bib58","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ygyno.2018.03.008","article-title":"Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: a multicenter review","volume":"149","author":"Stewart","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104683_bib59","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejca.2008.01.019","article-title":"Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)","volume":"44","author":"Reed","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijgc.2026.104683_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1748-717X-8-128","article-title":"Postoperative radiotherapy improves local control and survival in patients with uterine leiomyosarcoma","volume":"8","author":"Wong","year":"2013","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib61","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/ijgc-2018-000064","article-title":"Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group","volume":"29","author":"Meurer","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijgo.2013.01.025","article-title":"Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy","volume":"122","author":"Malouf","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijgc.2026.104683_bib63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21037\/gpm-20-65","article-title":"Radiotherapy in uterine sarcoma: a narrative review of international guidelines","volume":"4","author":"Ferioli","year":"2021","journal-title":"Gynecol Pelvic Med"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104683_bib64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"suppl 4","key":"10.1016\/j.ijgc.2026.104683_bib65","doi-asserted-by":"crossref","first-page":"iv51","DOI":"10.1093\/annonc\/mdy096","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104683_bib66","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/IGC.0000000000000261","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas","volume":"24","author":"Hensley","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib67","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/PGP.0000000000000284","article-title":"Distant metastases in uterine leiomyosarcomas: the wide variety of body sites and time intervals to metastatic relapse","volume":"36","author":"Bartosch","year":"2017","journal-title":"Int J Gynecol Pathol"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104683_bib68","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1200\/JCO.1985.3.9.1240","article-title":"A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study","volume":"3","author":"Omura","year":"1985","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104683_bib69","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2008.11.027","article-title":"Adjuvant gemcitabine plus docetaxel for completely resected stages I\u2013IV high grade uterine leiomyosarcoma: results of a prospective study","volume":"112","author":"Hensley","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104683_bib70","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/cncr.27942","article-title":"Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005)","volume":"119","author":"Hensley","year":"2013","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib71","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mds545","article-title":"A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group","volume":"24","author":"Pautier","year":"2013","journal-title":"Ann Oncol"},{"issue":"33","key":"10.1016\/j.ijgc.2026.104683_bib72","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00454","article-title":"Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: a phase III NRG oncology\/Gynecologic Oncology Group study","volume":"36","author":"Hensley","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2017.07.122","article-title":"Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: trends and survival outcomes","volume":"147","author":"Littell","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104683_bib74","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.currproblcancer.2019.06.001","article-title":"Uterine sarcomas","volume":"43","author":"Ganjoo","year":"2019","journal-title":"Curr Probl Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104683_bib75","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/cncr.23592","article-title":"A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma","volume":"113","author":"Pervaiz","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104683_bib76","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ygyno.2013.08.037","article-title":"Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?","volume":"131","author":"Ricci","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib77","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2019.12.008","article-title":"Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer\u00ae-accredited facilities","volume":"157","author":"Vaz","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"suppl 16","key":"10.1016\/j.ijgc.2026.104683_bib78","article-title":"Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS): a multicenter study","volume":"42","author":"Alshibany","year":"2024","journal-title":"J Clin Oncol."},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2011.10.010","article-title":"Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment","volume":"125","author":"Beck","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104683_bib80","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0090-8258(03)00258-0","article-title":"Low-grade endometrial stromal sarcoma: hormonal aspects","volume":"90","author":"Chu","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104683_bib81","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ygyno.2007.01.031","article-title":"A multi-institutional review of outcomes of endometrial stromal sarcoma","volume":"105","author":"Leath","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104683_bib82","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/JCMA.0000000000000039","article-title":"Hormone therapy following surgery in low-grade endometrial stromal sarcoma: is it related to a decrease in recurrence rate?","volume":"82","author":"Comert","year":"2019","journal-title":"J Chin Med Assoc"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:34:30Z","timestamp":1780306470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26002148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1048891X26002148"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104683","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary issues in the multi-disciplinary management of early-stage uterine sarcoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104683"}}